Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dentsply SironaXRAY -2.29%57 Earnings per Share (Diluted) is $-2.75 as of Jun. 2026. GuruFocus rates XRAY with a GF Score™ of 57/100 and a GF Value™ of $17.36 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 655 Medical Devices & Instruments companies, Dentsply Sirona ranks worse than 72.21% on this metric.
Dentsply Sirona's EPS (Basic) for the
three
months ended in Jun. 2026 was $0.18.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2026 was $-2.75.
During the past 12 months, Dentsply Sirona's average EPS without NRIGrowth Rate was -47.40% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was -8.50% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was -6.40% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was -4.80% per year.
During the past 13 years, Dentsply Sirona's highest 3-Year average EPS without NRI Growth Rate was 152.00% per year. The lowest was -16.50% per year. And the median was 9.70% per year.
Dentsply Sirona (NAS:XRAY) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Dentsply Sirona Earnings per Share (Diluted) Related Terms
Dentsply Sirona Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for Dentsply Sirona's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dentsply Sirona Earnings per Share (Diluted) Chart
XRAY vs LMAT, WRBY, PLSE: Earnings per Share (Diluted) Comparison
For the Medical Instruments & Supplies subindustry, Dentsply Sirona's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dentsply Sirona PE Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Dentsply Sirona's PE Ratio distribution charts can be found below:
* The bar in red indicates where Dentsply Sirona's PE Ratio falls into.
Dentsply Sirona Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
Dentsply Sirona's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2025 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.75
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of $-2.75 mean?
Dentsply Sirona (XRAY) has a Earnings per Share (Diluted) of $-2.75 as of Jun. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Dentsply Sirona and its competitors. According to the industry distribution chart, Dentsply Sirona ranks #473 out of 655 companies in the Medical Devices & Instruments industry, placing it in the top 72.2%.
Is Dentsply Sirona's Earnings per Share (Diluted) too high?
Dentsply Sirona's current Earnings per Share (Diluted) is $-2.75. Based on the distribution chart, Dentsply Sirona ranks #473 out of 655 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Dentsply Sirona has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Dentsply Sirona's Earnings per Share (Diluted) compare to LMAT and WRBY?
According to the Medical Devices & Instruments industry distribution chart, Dentsply Sirona ranks #473 out of 655 companies for Earnings per Share (Diluted). This places Dentsply Sirona in the lower half of its industry. The industry median Earnings per Share (Diluted) is 8.10. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Medical Devices & Instruments company?
The median Earnings per Share (Diluted) among Medical Devices & Instruments companies is 8.10, based on 655 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Dentsply Sirona and its competitors. For the Medical Devices & Instruments industry, the median Earnings per Share (Diluted) is 8.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dentsply Sirona's current Earnings per Share (Diluted) is $-2.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dentsply Sirona stock overvalued right now?
Based on GuruFocus' analysis, Dentsply Sirona (XRAY) is currently considered Possible Value Trap. The stock's GF Value™ is $17.36, compared to a current price of $11.33 — trading 34.8% below its estimated fair value. The current Earnings per Share (Diluted) is $-2.75. Dentsply Sirona's overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For Dentsply Sirona (XRAY), the current Earnings per Share (Diluted) is $-2.75 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dentsply Sirona (XRAY) Overvalued in 2026?
Based on GuruFocus' analysis, Dentsply Sirona stock appears to be undervalued.
The current stock price of $11.33 is trading 34.8% below its estimated GF Value™ of $17.36.
GuruFocus considers Dentsply Sirona to be Possible Value Trap.
Key valuation signals for XRAY:
Earnings per Share (Diluted): $-2.75
GF Value™: $17.36 vs. price of $11.33 (34.8% below fair value)
No single metric tells the full story. See the XRAY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).
57GF Score
Get the complete analysis for XRAY
Earnings per Share (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XRAY has been successfully added to your 
